Skip to main content
Top
Published in: Critical Care 2/2011

Open Access 01-04-2011 | Research

Activation of factor VII-activating protease in human inflammation: a sensor for cell death

Authors: Femke Stephan, Jan A Hazelzet, Ingrid Bulder, Marja A Boermeester, JW Olivier van Till, Tom van der Poll, Walter A Wuillemin, Lucien A Aarden, Sacha Zeerleder

Published in: Critical Care | Issue 2/2011

Login to get access

Abstract

Introduction

Cell death is a central event in the pathogenesis of sepsis and is reflected by circulating nucleosomes. Circulating nucleosomes were suggested to play an important role in inflammation and were demonstrated to correlate with severity and outcome in sepsis patients. We recently showed that plasma can release nucleosomes from late apoptotic cells. Factor VII-activating protease (FSAP) was identified to be the plasma serine protease responsible for nucleosome release. The aim of this study was to investigate FSAP activation in patients suffering from various inflammatory diseases of increasing severity.

Methods

We developed ELISAs to measure FSAP-C1-inhibitor and FSAP-α2-antiplasmin complexes in plasma. FSAP-inhibitor complexes were measured in the plasma of 20 adult patients undergoing transhiatal esophagectomy, 32 adult patients suffering from severe sepsis and 8 from septic shock and 38 children suffering from meningococcal sepsis.

Results

We demonstrate plasma FSAP to be activated upon contact with apoptotic and necrotic cells by an assay detecting complexes between FSAP and its target serpins α2-antiplasmin and C1-inhibitor, respectively. By means of that assay we demonstrate FSAP activation in post-surgery patients, patients suffering from severe sepsis, septic shock and meningococcal sepsis. Levels of FSAP-inhibitor complexes correlate with nucleosome levels and correlate with severity and mortality in these patients.

Conclusions

These results suggest FSAP activation to be a sensor for cell death in the circulation and that FSAP activation in sepsis might be involved in nucleosome release, thereby contributing to lethality.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995, 273: 117-123. 10.1001/jama.273.2.117CrossRefPubMed Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995, 273: 117-123. 10.1001/jama.273.2.117CrossRefPubMed
2.
go back to reference Papathanassoglou EDE, Moynihan JA, Ackerman MH: Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patients? A review and theoretical framework. Crit Care Med 2000, 28: 537-549. 10.1097/00003246-200002000-00042CrossRefPubMed Papathanassoglou EDE, Moynihan JA, Ackerman MH: Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patients? A review and theoretical framework. Crit Care Med 2000, 28: 537-549. 10.1097/00003246-200002000-00042CrossRefPubMed
3.
go back to reference Coopersmith CM, Stromberg PE, Dunne WM, Davis CG, Amiot DM, Buchman TG, Karl IE, Hotchkiss RS: Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA 2002, 287: 1716-1721. 10.1001/jama.287.13.1716CrossRefPubMed Coopersmith CM, Stromberg PE, Dunne WM, Davis CG, Amiot DM, Buchman TG, Karl IE, Hotchkiss RS: Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA 2002, 287: 1716-1721. 10.1001/jama.287.13.1716CrossRefPubMed
4.
go back to reference Hotchkiss RS, Swanson PE, Cobb JP, Jacobson A, Buchman TG, Karl IE: Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice. Crit Care Med 1997, 25: 1298-1307. 10.1097/00003246-199708000-00015CrossRefPubMed Hotchkiss RS, Swanson PE, Cobb JP, Jacobson A, Buchman TG, Karl IE: Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice. Crit Care Med 1997, 25: 1298-1307. 10.1097/00003246-199708000-00015CrossRefPubMed
5.
go back to reference Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, Buchman TG, Karl IE: Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999, 27: 1230-1251. 10.1097/00003246-199907000-00002CrossRefPubMed Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, Buchman TG, Karl IE: Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999, 27: 1230-1251. 10.1097/00003246-199907000-00002CrossRefPubMed
6.
go back to reference Zeerleder S, Zwart B, Wuillemin WA, Aarden LA, Groeneveld AB, Caliezi C, van Nieuwenhuijze AE, van Mierlo GJ, Eerenberg AJ, Lammle B, Hack CE: Elevated nucleosome levels in systemic inflammation and sepsis. Crit Care Med 2003, 31: 1947-1951. 10.1097/01.CCM.0000074719.40109.95CrossRefPubMed Zeerleder S, Zwart B, Wuillemin WA, Aarden LA, Groeneveld AB, Caliezi C, van Nieuwenhuijze AE, van Mierlo GJ, Eerenberg AJ, Lammle B, Hack CE: Elevated nucleosome levels in systemic inflammation and sepsis. Crit Care Med 2003, 31: 1947-1951. 10.1097/01.CCM.0000074719.40109.95CrossRefPubMed
7.
go back to reference van Till JW, van Veen SQ, den Broeder V, Bresser P, Lutter R, Out TA, Schultz MJ, Gouma DJ, Boermeester MA: Compartmental apoptosis and neutrophil accumulation in severe peritonitis. J Surg Res 2010, 164: 321-328. 10.1016/j.jss.2009.09.020CrossRefPubMed van Till JW, van Veen SQ, den Broeder V, Bresser P, Lutter R, Out TA, Schultz MJ, Gouma DJ, Boermeester MA: Compartmental apoptosis and neutrophil accumulation in severe peritonitis. J Surg Res 2010, 164: 321-328. 10.1016/j.jss.2009.09.020CrossRefPubMed
8.
go back to reference Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, Taylor FB, Esmon NL, Lupu F, Esmon CT: Extracellular histones are major mediators of death in sepsis. Nat Med 2009, 15: 1318-1321. 10.1038/nm.2053PubMedCentralCrossRefPubMed Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, Taylor FB, Esmon NL, Lupu F, Esmon CT: Extracellular histones are major mediators of death in sepsis. Nat Med 2009, 15: 1318-1321. 10.1038/nm.2053PubMedCentralCrossRefPubMed
9.
go back to reference Zeerleder S, Zwart B, Te VH, Manoe R, Bulder I, Rensink I, Aarden LA: A plasma nucleosome releasing factor (NRF) with serine protease activity is instrumental in removal of nucleosomes from secondary necrotic cells. FEBS Lett 2007, 581: 5382-5388.CrossRefPubMed Zeerleder S, Zwart B, Te VH, Manoe R, Bulder I, Rensink I, Aarden LA: A plasma nucleosome releasing factor (NRF) with serine protease activity is instrumental in removal of nucleosomes from secondary necrotic cells. FEBS Lett 2007, 581: 5382-5388.CrossRefPubMed
10.
go back to reference Zeerleder S, Zwart B, Te VH, Stephan F, Manoe R, Rensink I, Aarden LA: Nucleosome-releasing factor: a new role for factor VII-activating protease (FSAP). FASEB J 2008, 22: 4077-4084. 10.1096/fj.08-110429CrossRefPubMed Zeerleder S, Zwart B, Te VH, Stephan F, Manoe R, Rensink I, Aarden LA: Nucleosome-releasing factor: a new role for factor VII-activating protease (FSAP). FASEB J 2008, 22: 4077-4084. 10.1096/fj.08-110429CrossRefPubMed
11.
go back to reference Etscheid M, Hunfeld A, Konig H, Seitz R, Dodt J: Activation of proPHBSP, the zymogen of a plasma hyaluronan binding serine protease, by an intermolecular autocatalytic mechanism. Biol Chem 2000, 381: 1223-1231. 10.1515/BC.2000.150CrossRefPubMed Etscheid M, Hunfeld A, Konig H, Seitz R, Dodt J: Activation of proPHBSP, the zymogen of a plasma hyaluronan binding serine protease, by an intermolecular autocatalytic mechanism. Biol Chem 2000, 381: 1223-1231. 10.1515/BC.2000.150CrossRefPubMed
12.
go back to reference Kannemeier C, Feussner A, Stohr HA, Weisse J, Preissner KT, Romisch J: Factor VII and single-chain plasminogen activator-activating protease: activation and autoactivation of the proenzyme. Eur J Biochem 2001, 268: 3789-3796. 10.1046/j.1432-1327.2001.02285.xCrossRefPubMed Kannemeier C, Feussner A, Stohr HA, Weisse J, Preissner KT, Romisch J: Factor VII and single-chain plasminogen activator-activating protease: activation and autoactivation of the proenzyme. Eur J Biochem 2001, 268: 3789-3796. 10.1046/j.1432-1327.2001.02285.xCrossRefPubMed
13.
go back to reference Nakazawa F, Kannemeier C, Shibamiya A, Song Y, Tzima E, Schubert U, Koyama T, Niepmann M, Trusheim H, Engelmann B, Preissner KT: Extracellular RNA is a natural cofactor for the (auto-)activation of Factor VII-activating protease (FSAP). Biochem J 2005, 385: 831-838. 10.1042/BJ20041021PubMedCentralCrossRefPubMed Nakazawa F, Kannemeier C, Shibamiya A, Song Y, Tzima E, Schubert U, Koyama T, Niepmann M, Trusheim H, Engelmann B, Preissner KT: Extracellular RNA is a natural cofactor for the (auto-)activation of Factor VII-activating protease (FSAP). Biochem J 2005, 385: 831-838. 10.1042/BJ20041021PubMedCentralCrossRefPubMed
14.
go back to reference Muhl L, Galuska SP, Oorni K, Hernandez-Ruiz L, Andrei-Selmer LC, Geyer R, Preissner KT, Ruiz FA, Kovanen PT, Kanse SM: High negative charge-to-size ratio in polyphosphates and heparin regulates factor VII-activating protease. FEBS J 2009, 276: 4828-4839. 10.1111/j.1742-4658.2009.07183.xCrossRefPubMed Muhl L, Galuska SP, Oorni K, Hernandez-Ruiz L, Andrei-Selmer LC, Geyer R, Preissner KT, Ruiz FA, Kovanen PT, Kanse SM: High negative charge-to-size ratio in polyphosphates and heparin regulates factor VII-activating protease. FEBS J 2009, 276: 4828-4839. 10.1111/j.1742-4658.2009.07183.xCrossRefPubMed
15.
go back to reference Shibamiya A, Muhl L, Tannert-Otto S, Preissner KT, Kanse SM: Nucleic acids potentiate Factor VII-activating protease (FSAP)-mediated cleavage of platelet-derived growth factor-BB and inhibition of vascular smooth muscle cell proliferation. Biochem J 2007, 404: 45-50. 10.1042/BJ20070166PubMedCentralCrossRefPubMed Shibamiya A, Muhl L, Tannert-Otto S, Preissner KT, Kanse SM: Nucleic acids potentiate Factor VII-activating protease (FSAP)-mediated cleavage of platelet-derived growth factor-BB and inhibition of vascular smooth muscle cell proliferation. Biochem J 2007, 404: 45-50. 10.1042/BJ20070166PubMedCentralCrossRefPubMed
16.
go back to reference Choi-Miura NH, Saito K, Takahashi K, Yoda M, Tomita M: Regulation mechanism of the serine protease activity of plasma hyaluronan binding protein. Biol Pharm Bull 2001, 24: 221-225. 10.1248/bpb.24.221CrossRefPubMed Choi-Miura NH, Saito K, Takahashi K, Yoda M, Tomita M: Regulation mechanism of the serine protease activity of plasma hyaluronan binding protein. Biol Pharm Bull 2001, 24: 221-225. 10.1248/bpb.24.221CrossRefPubMed
17.
go back to reference Romisch J, Vermohlen S, Feussner A, Stohr H: The FVII activating protease cleaves single-chain plasminogen activators. Haemostasis 1999, 29: 292-299.PubMed Romisch J, Vermohlen S, Feussner A, Stohr H: The FVII activating protease cleaves single-chain plasminogen activators. Haemostasis 1999, 29: 292-299.PubMed
18.
go back to reference Hunfeld A, Etscheid M, Konig H, Seitz R, Dodt J: Detection of a novel plasma serine protease during purification of vitamin K-dependent coagulation factors. FEBS Lett 1999, 456: 290-294. 10.1016/S0014-5793(99)00959-XCrossRefPubMed Hunfeld A, Etscheid M, Konig H, Seitz R, Dodt J: Detection of a novel plasma serine protease during purification of vitamin K-dependent coagulation factors. FEBS Lett 1999, 456: 290-294. 10.1016/S0014-5793(99)00959-XCrossRefPubMed
19.
go back to reference Wygrecka M, Morty RE, Markart P, Kanse SM, Andreasen PA, Wind T, Guenther A, Preissner KT: Plasminogen activator inhibitor-1 is an inhibitor of factor VII-activating protease in patients with acute respiratory distress syndrome. J Biol Chem 2007, 282: 21671-21682. 10.1074/jbc.M610748200CrossRefPubMed Wygrecka M, Morty RE, Markart P, Kanse SM, Andreasen PA, Wind T, Guenther A, Preissner KT: Plasminogen activator inhibitor-1 is an inhibitor of factor VII-activating protease in patients with acute respiratory distress syndrome. J Biol Chem 2007, 282: 21671-21682. 10.1074/jbc.M610748200CrossRefPubMed
20.
go back to reference van Till JW, Boermeester MA, Modderman PW, Van Sandick JW, Hart MH, Gisbertz SS, Van Lanschot JJ, Aarden LA: Variable mannose-binding lectin expression during postoperative acute-phase response. Surg Infect (Larchmt) 2006, 7: 443-452. 10.1089/sur.2006.7.443CrossRef van Till JW, Boermeester MA, Modderman PW, Van Sandick JW, Hart MH, Gisbertz SS, Van Lanschot JJ, Aarden LA: Variable mannose-binding lectin expression during postoperative acute-phase response. Surg Infect (Larchmt) 2006, 7: 443-452. 10.1089/sur.2006.7.443CrossRef
21.
go back to reference Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101: 1644-1655. 10.1378/chest.101.6.1644CrossRefPubMed Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101: 1644-1655. 10.1378/chest.101.6.1644CrossRefPubMed
22.
go back to reference Caliezi C, Zeerleder S, Redondo M, Regli B, Rothen HU, Zürcher-Zenklusen R, Rieben R, Devay J, Hack CE, Lämmle B, Wuillemin WA: C1-inhibitor in patients with severe sepsis and septic shock: beneficial effect on renal dysfunction. Crit Care Med 2002, 30: 1722-1728. 10.1097/00003246-200208000-00008CrossRefPubMed Caliezi C, Zeerleder S, Redondo M, Regli B, Rothen HU, Zürcher-Zenklusen R, Rieben R, Devay J, Hack CE, Lämmle B, Wuillemin WA: C1-inhibitor in patients with severe sepsis and septic shock: beneficial effect on renal dysfunction. Crit Care Med 2002, 30: 1722-1728. 10.1097/00003246-200208000-00008CrossRefPubMed
23.
go back to reference Hazelzet JA, de Kleijn ED, de Groot R: Endothelial protein C activation in meningococcal sepsis. N Engl J Med 2001, 345: 1776-1777.CrossRefPubMed Hazelzet JA, de Kleijn ED, de Groot R: Endothelial protein C activation in meningococcal sepsis. N Engl J Med 2001, 345: 1776-1777.CrossRefPubMed
24.
go back to reference Nuijens JH, Huijbregts CC, Eerenberg-Belmer AJ, Abbink JJ, Strack van Schijndel RJ, Felt-Bersma RJ, Thijs LG, Hack CE: Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis. Blood 1988, 72: 1841-1848.PubMed Nuijens JH, Huijbregts CC, Eerenberg-Belmer AJ, Abbink JJ, Strack van Schijndel RJ, Felt-Bersma RJ, Thijs LG, Hack CE: Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis. Blood 1988, 72: 1841-1848.PubMed
25.
go back to reference Roemisch J, Feussner A, Nerlich C, Stoehr HA, Weimer T: The frequent Marburg I polymorphism impairs the pro-urokinase activating potency of the factor VII activating protease (FSAP). Blood Coagul Fibrinolysis 2002, 13: 433-441. 10.1097/00001721-200207000-00008CrossRefPubMed Roemisch J, Feussner A, Nerlich C, Stoehr HA, Weimer T: The frequent Marburg I polymorphism impairs the pro-urokinase activating potency of the factor VII activating protease (FSAP). Blood Coagul Fibrinolysis 2002, 13: 433-441. 10.1097/00001721-200207000-00008CrossRefPubMed
26.
go back to reference Rümke CL, Bezemer PD: [Methods for determination of normal levels. II. Current methods]. Ned Tijdschr Geneeskd 1972, 116: 1559-1568.PubMed Rümke CL, Bezemer PD: [Methods for determination of normal levels. II. Current methods]. Ned Tijdschr Geneeskd 1972, 116: 1559-1568.PubMed
27.
go back to reference Huntington JA, Read RJ, Carrell RW: Structure of a serpin-protease complex shows inhibition by deformation. Nature 2000, 407: 923-926. 10.1038/35038119CrossRefPubMed Huntington JA, Read RJ, Carrell RW: Structure of a serpin-protease complex shows inhibition by deformation. Nature 2000, 407: 923-926. 10.1038/35038119CrossRefPubMed
28.
go back to reference Schapira M, de Agostini A, Colman RW: C1 inhibitor: the predominant inhibitor of plasma kallikrein. Methods Enzymol 1988, 163: 179-185.CrossRefPubMed Schapira M, de Agostini A, Colman RW: C1 inhibitor: the predominant inhibitor of plasma kallikrein. Methods Enzymol 1988, 163: 179-185.CrossRefPubMed
Metadata
Title
Activation of factor VII-activating protease in human inflammation: a sensor for cell death
Authors
Femke Stephan
Jan A Hazelzet
Ingrid Bulder
Marja A Boermeester
JW Olivier van Till
Tom van der Poll
Walter A Wuillemin
Lucien A Aarden
Sacha Zeerleder
Publication date
01-04-2011
Publisher
BioMed Central
Published in
Critical Care / Issue 2/2011
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc10131

Other articles of this Issue 2/2011

Critical Care 2/2011 Go to the issue